Why KLRS? Kalaris Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
KLRS
$5.46-0.06 (-1.09%)
Market ClosedLast close May 1
Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases.